The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors.
about
The mechanism of action of sodium-glucose co-transporter 2 inhibitors is similar to carbonic anhydrase inhibitors.The year in cardiology 2017: heart failure.Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study).Cardiovascular Effects of New Oral Glucose-Lowering Agents: DPP-4 and SGLT-2 Inhibitors.Exploration of the clinical benefits of sodium glucose co-transporter 2 inhibitors in diabetic patients with concomitant heart failure.Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysisEmpagliflozin, calcium, and SGLT1/2 receptor affinity: another piece of the puzzleDiabetic Cardiomyopathy: Current and Future Therapies. Beyond Glycemic Control
P2860
Q49684031-65310442-81CE-42AB-AFDC-571C03F0A8A7Q50193302-A1498AE8-AFA3-448E-9055-55CD0A3DA1D0Q52661895-A41D499C-D6B0-495B-BDA8-D3C67EDDFB81Q55053753-1D66D25D-5B5F-4ECD-A749-4FCD18CCC2FCQ55240908-E4E16CB3-4B69-4F23-B2A6-D26D0BF5BA61Q55879040-F99C09A4-EF8C-4023-83CB-4C8153F99823Q56956663-C7EBB96D-683F-4F23-A23C-A8FE5069954CQ58698076-6B23299C-2C83-46AC-B937-49C78B5248F7
P2860
The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The potential role and rationa ...... e co-transporter 2 inhibitors.
@en
type
label
The potential role and rationa ...... e co-transporter 2 inhibitors.
@en
prefLabel
The potential role and rationa ...... e co-transporter 2 inhibitors.
@en
P2093
P2860
P50
P356
P1476
The potential role and rationa ...... e co-transporter 2 inhibitors.
@en
P2093
Afshin Salsali
Alfred K Cheung
Benjamin M Scirica
Carine E Hamo
Carolyn S P Lam
Christoph Wanner
Cyrus R Mehta
EMPEROR Trials Program
Hans-Juergan Woerle
Hiroyuki Tsutsui
P2860
P356
10.1002/EJHF.933
P50
P577
2017-08-24T00:00:00Z